FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082378627> ?p ?o ?g. }

• W2082378627 endingPage "474" @default.
• W2082378627 startingPage "470" @default.
• W2082378627 abstract "Lymphocyte activation markers CD69 and HLA-DR were studied in metastatic breast and ovarian cancer patients who received active specific immunotherapy (ASI) using cancer vaccines containing the synthetic tumor-associated antigen sialyl-Tn or the Thomsen-Friedenreich antigen conjugated to KLH plus DETOX adjuvant. Breast cancer patients who showed prolonged survival following ASI had lower numbers of total CD69+ and CD4+CD69+ cells prior to ASI compared to patients who died. However, following ASI, the surviving patients showed an increase in CD69+ and CD4+CD69+ cells and the deceased patients showed a decrease. A greater than 50% increase in the percentage of cells bearing the activation marker CD69 is associated with an increase in survival in both ovarian and breast cancer patients. In the surviving breast cancer patients there was a significant decrease in the percentage of non-B lymphocyte HLA-DR+ (CD20−HLA-DR+) cells following cyclophosphamide treatment. A strong positive correlation was found between lymphocyte populations CD20− HLA-DR+ and CD8+CD57+, a putative suppressor cell population. Breast cancer patients who showed a greater than median decrease in CD20−HLA-DR+ lymphocytes following cyclophosphamide treatment had a survival advantage over patients who had less than the median decrease in the percent CD20−HLA-DR+ lymphocytes. © 1995 Wiley-Liss, Inc." @default.
• W2082378627 created "2016-06-24" @default.
• W2082378627 creator A5011462216 @default.
• W2082378627 creator A5035112153 @default.
• W2082378627 creator A5061164290 @default.
• W2082378627 creator A5066365985 @default.
• W2082378627 creator A5074985906 @default.
• W2082378627 creator A5083319626 @default.
• W2082378627 creator A5085810674 @default.
• W2082378627 date "1995-05-16" @default.
• W2082378627 modified "2023-10-14" @default.
• W2082378627 title "CD69+ and HLA-DR+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: Correlations with survival following active specific immunotherapy" @default.
• W2082378627 cites W1966496992 @default.
• W2082378627 cites W1977436632 @default.
• W2082378627 cites W1989335432 @default.
• W2082378627 cites W2015095588 @default.
• W2082378627 cites W2022248729 @default.
• W2082378627 cites W2029844324 @default.
• W2082378627 cites W2031450009 @default.
• W2082378627 cites W2037219506 @default.
• W2082378627 cites W2048917176 @default.
• W2082378627 cites W2089075738 @default.
• W2082378627 cites W2172523660 @default.
• W2082378627 cites W2412160309 @default.
• W2082378627 cites W2419469656 @default.
• W2082378627 cites W289124853 @default.
• W2082378627 doi "https://doi.org/10.1002/ijc.2910610407" @default.
• W2082378627 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7538976" @default.
• W2082378627 hasPublicationYear "1995" @default.
• W2082378627 type Work @default.
• W2082378627 sameAs 2082378627 @default.
• W2082378627 citedByCount "40" @default.
• W2082378627 countsByYear W20823786272014 @default.
• W2082378627 countsByYear W20823786272016 @default.
• W2082378627 countsByYear W20823786272018 @default.
• W2082378627 countsByYear W20823786272021 @default.
• W2082378627 crossrefType "journal-article" @default.
• W2082378627 hasAuthorship W2082378627A5011462216 @default.
• W2082378627 hasAuthorship W2082378627A5035112153 @default.
• W2082378627 hasAuthorship W2082378627A5061164290 @default.
• W2082378627 hasAuthorship W2082378627A5066365985 @default.
• W2082378627 hasAuthorship W2082378627A5074985906 @default.
• W2082378627 hasAuthorship W2082378627A5083319626 @default.
• W2082378627 hasAuthorship W2082378627A5085810674 @default.
• W2082378627 hasConcept C121608353 @default.
• W2082378627 hasConcept C126322002 @default.
• W2082378627 hasConcept C143998085 @default.
• W2082378627 hasConcept C147483822 @default.
• W2082378627 hasConcept C167672396 @default.
• W2082378627 hasConcept C18031839 @default.
• W2082378627 hasConcept C203014093 @default.
• W2082378627 hasConcept C2775930923 @default.
• W2082378627 hasConcept C2776694085 @default.
• W2082378627 hasConcept C2776755627 @default.
• W2082378627 hasConcept C2777701055 @default.
• W2082378627 hasConcept C2777761686 @default.
• W2082378627 hasConcept C2779616870 @default.
• W2082378627 hasConcept C2780427987 @default.
• W2082378627 hasConcept C2908647359 @default.
• W2082378627 hasConcept C530470458 @default.
• W2082378627 hasConcept C71924100 @default.
• W2082378627 hasConcept C99454951 @default.
• W2082378627 hasConceptScore W2082378627C121608353 @default.
• W2082378627 hasConceptScore W2082378627C126322002 @default.
• W2082378627 hasConceptScore W2082378627C143998085 @default.
• W2082378627 hasConceptScore W2082378627C147483822 @default.
• W2082378627 hasConceptScore W2082378627C167672396 @default.
• W2082378627 hasConceptScore W2082378627C18031839 @default.
• W2082378627 hasConceptScore W2082378627C203014093 @default.
• W2082378627 hasConceptScore W2082378627C2775930923 @default.
• W2082378627 hasConceptScore W2082378627C2776694085 @default.
• W2082378627 hasConceptScore W2082378627C2776755627 @default.
• W2082378627 hasConceptScore W2082378627C2777701055 @default.
• W2082378627 hasConceptScore W2082378627C2777761686 @default.
• W2082378627 hasConceptScore W2082378627C2779616870 @default.
• W2082378627 hasConceptScore W2082378627C2780427987 @default.
• W2082378627 hasConceptScore W2082378627C2908647359 @default.
• W2082378627 hasConceptScore W2082378627C530470458 @default.
• W2082378627 hasConceptScore W2082378627C71924100 @default.
• W2082378627 hasConceptScore W2082378627C99454951 @default.
• W2082378627 hasIssue "4" @default.
• W2082378627 hasLocation W20823786271 @default.
• W2082378627 hasLocation W20823786272 @default.
• W2082378627 hasOpenAccess W2082378627 @default.
• W2082378627 hasPrimaryLocation W20823786271 @default.
• W2082378627 hasRelatedWork W1985946749 @default.
• W2082378627 hasRelatedWork W2035667867 @default.
• W2082378627 hasRelatedWork W2046757880 @default.
• W2082378627 hasRelatedWork W2047217903 @default.
• W2082378627 hasRelatedWork W2088956065 @default.
• W2082378627 hasRelatedWork W2127084226 @default.
• W2082378627 hasRelatedWork W2340535554 @default.
• W2082378627 hasRelatedWork W2352165281 @default.
• W2082378627 hasRelatedWork W2362001173 @default.
• W2082378627 hasRelatedWork W2184375286 @default.
• W2082378627 hasVolume "61" @default.
• W2082378627 isParatext "false" @default.
• W2082378627 isRetracted "false" @default.

• next